Where To Invest In Robotic Surgery

Published: Sunday, June 22, 2025 at 2:33 pm

Robotic Surgery: A Market Poised for Growth

The field of robotic surgery is experiencing rapid expansion, with revenue projected to double by 2029, reaching $23.7 billion. This growth is fueled by the precision and remote capabilities of surgical robots, offering advantages such as enhanced accuracy and the ability for surgeons to operate from a distance.

The market is currently dominated by Intuitive Surgical, the maker of the da Vinci Surgical System. Intuitive's shares have performed well, and the company boasts strong revenue and earnings growth, with a commendable profit margin. However, the company's stock is not cheap, and its market capitalization is substantial.

A promising alternative is SS Innovations, a newer entrant in the field. Founded in 2019, SS Innovations has demonstrated encouraging growth, with annual revenue increasing significantly. The company's strategic position is strengthened by its price advantage over Intuitive's da Vinci system. SS Innovations is led by Dr. Sudhir Srivastava, the CEO, and Dr. Frederic Moll, the vice chairman. The company's SSi Mantra device is used globally, and it is targeting the U.S. and European markets.

SS Innovations is focusing on community hospitals and ambulatory surgical centers in medically underserved areas. The company has performed thousands of surgeries across various categories.

BNN's Perspective:

While Intuitive Surgical remains a dominant player with a proven track record, the potential of SS Innovations as a value play is noteworthy. The company's focus on affordability and its expansion into underserved markets could position it for significant growth. Investors should carefully consider the risks associated with a newer company, but the potential rewards are also substantial.

Keywords: Robotic surgery, SS Innovations, Intuitive Surgical, da Vinci Surgical System, investment, healthcare, medical technology, surgical robots, market growth, Dr. Sudhir Srivastava, Dr. Frederic Moll, SSi Mantra, minimally invasive surgery

Full Story